NIH Launches COVID-19 Neuro Databank/Biobank to Track Neurological Symptoms Associated with COVID-19
A new database will collect information from clinicians about COVID-19-related neurological symptoms, complications, and outcomes as well as COVID-19 effects on pre-existing neurological conditions. The COVID-19 Neuro Databank/Biobank (NeuroCOVID), which was created and will be maintained by NYU Langone...
ISBER Releases Position Statement for Management and Use of Ultra Low Temperature Freezers
The International Society for the Biological and Environmental Repositories (ISBER), which represents professional experts in biobanking, ultra-low temperature (ULT) storage and cold chain management, has released its position statement listing key practices health agencies should consider to support the...
Using Biobank Data to Estimate Genetic Variants Associated with Mortality in COVID-19 Patients
Coronavirus disease 2019 (COVID-19) is a highly infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)1. The severity of COVID-19 and course of the infection is highly heterogenous. The majority of COVID-19 cases only have mild or...
Establishing A Pediatric COVID-19 Biorepository
The global pandemic of COVID-19, caused by the highly infectious and transmissible coronavirus, SARS-CoV-2, has become a leading cause of death in older adults. The risk of severe disease and death has been highest in older patients and in...
Complement And Coagulation Disorders Associated With COVID-19
Recent structure based comparisons suggest that coronavirus proteins mimic at least 140 human proteins, including those in the complement and coagulation pathways. The complement cascade leading to cell death and inflammation is part of the innate immune system, and...
COVID-19 Risk In Different Ethnic And Socioeconomic Groups Within UK Biobank
Socioeconomic and ethnic factors may influence the risk of viral infection. For example, both economic circumstances and cultural influences may impact the extent to which people can implement distancing measures, thus modifying their risk. The extent to which this...
Vitamin D Status Did Not Predict COVID-19 Infection Risk In The UK Biobank
A recent meta-analysis of 25 clinical trials located in 15 countries conducted by the UK National Health Service (NHS), Institute for Health Research, indicated that vitamin D supplements reduced the risk of acute respiratory infection (ARI) from 42% to...
SARS-CoV-2 Detected In French Biobank Sample Collected In Late 2019
COVID-19 is a respiratory disease pandemic that has swept across the world, causing over 282,495 deaths (May 10, 2020). Patients most commonly present at hospitals with influenza-like illness (ILI). The causative agent of COVID-19, the coronavirus SARS-CoV-2, has no...
CloudLIMS Redefines Operations in COVID-19 Biobanks with its Ready-to-go-live COVID-19 LIMS
Wilmington, Delaware – May 08, 2020, CloudLIMS, a leading provider of laboratory informatics, announces the launch of a ready-to-go-live COVID-19 LIMS. CloudLIMS is preconfigured with CDC approved COVID-19 biorepository SOPs and can be quickly set up in less than a week.
With...
Matrix LIMS Used by Liverpool GCPLab in UK Wide Tracking of COVID-19 Patient Outcomes
The Liverpool Good Clinical Practice Laboratory (GCPLab) Facility directed by Professor Bill Greenhalf, has a crucial role in supporting the International Severe Acute Respiratory and Emerging Infection Consortium - Coronavirus Clinical Characterisation Consortium (ISARIC-4C) run the Clinical Characterisation Protocol...
